Specific compounds like tesamorelin, AOD-9604, CJC-1295 paired with ipamorelin, MOTS-c, and GLP-1 receptor agonists target the biological mechanisms that make belly fat so persistent
Ralf Jockers (Inserm/CNRS, Universit Paris Cit), researchers have found the significant role of DNA mutations in the glucagon-like peptide 1 receptor (GLP1R) and their profound effects on metabolic traits related to diabetes and obesity
It's important to note that semaglutide carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Signaling inflammation across the gut-brain axis
It should be noted that these findings do not imply that DPP-4 inhibitors are harmful in any way or that GLP-1 drugs are definitely beneficial for brain health. Kornelius also noted that tirzepatide, a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, was not evaluated since it was approved after the beginning of the study period.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are broadly regarded as effective drugs in the treatment of type 2 diabetes mellitus (T2DM)
